{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:35:58Z","timestamp":1792096558474,"version":"4.4.0"},"reference-count":62,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:p>Osteoporosis is a major health problem leading to fractures that cause substantial morbidity and mortality. Current osteoporosis therapies have significant drawbacks, creating a need for novel bone-anabolic agents. We previously showed that the nitric oxide\/cyclic GMP (cGMP)\/protein kinase G pathway mediates some of the anabolic effects of estrogens and mechanical stimulation in osteoblasts and osteocytes, leading us to hypothesize that cGMP-elevating agents may have bone-protective effects. We tested cinaciguat, a prototype of a novel class of soluble guanylate cyclase activators, in a mouse model of estrogen deficiency-induced osteoporosis. Compared with sham-operated mice, ovariectomized mice had lower serum cGMP concentrations, which were largely restored to normal by treatment with cinaciguat or low-dose 17\u03b2-estradiol. Microcomputed tomography of tibiae showed that cinaciguat significantly improved trabecular bone microarchitecture in ovariectomized animals, with effect sizes similar to those obtained with estrogen replacement therapy. Cinaciguat reversed ovariectomy-induced osteocyte apoptosis as efficiently as estradiol and enhanced bone formation parameters in vivo, consistent with in vitro effects on osteoblast proliferation, differentiation, and survival. Compared with 17\u03b2-estradiol, which completely reversed the ovariectomy-induced increase in osteoclast number, cinaciguat had little effect on osteoclasts. Direct guanylate cyclase stimulators have been extremely well tolerated in clinical trials of cardiovascular diseases, and our findings provide proof-of-concept for this new class of drugs as a novel, anabolic treatment strategy for postmenopausal osteoporosis, confirming an important role of nitric oxide\/cGMP\/protein kinase G signaling in bone.<\/jats:p>","DOI":"10.1210\/en.2014-1343","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T17:09:04Z","timestamp":1409850544000},"page":"4720-4730","source":"Crossref","is-referenced-by-count":43,"title":["Soluble Guanylate Cyclase as a Novel Treatment Target for Osteoporosis"],"prefix":"10.1210","volume":"155","author":[{"given":"Jisha","family":"Joshua","sequence":"first","affiliation":[{"name":"Departments of Medicine (J.J., G.K.S., H.K., G.R.B., R.B.P.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerburg K.","family":"Schwaerzer","sequence":"first","affiliation":[{"name":"Departments of Medicine (J.J., G.K.S., H.K., G.R.B., R.B.P.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Kalyanaraman","sequence":"first","affiliation":[{"name":"Departments of Medicine (J.J., G.K.S., H.K., G.R.B., R.B.P.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Cory","sequence":"first","affiliation":[{"name":"Bioengineering (E.C., R.S.S.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Sah","sequence":"first","affiliation":[{"name":"Bioengineering (E.C., R.S.S.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mofei","family":"Li","sequence":"first","affiliation":[{"name":"Mathematics (M.L.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Vaida","sequence":"first","affiliation":[{"name":"Family and Preventive Medicine (F.V.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry R.","family":"Boss","sequence":"first","affiliation":[{"name":"Departments of Medicine (J.J., G.K.S., H.K., G.R.B., R.B.P.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate B.","family":"Pilz","sequence":"first","affiliation":[{"name":"Departments of Medicine (J.J., G.K.S., H.K., G.R.B., R.B.P.), University of California, San Diego, La Jolla, California 92093\u20130652"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071612020144500_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.16.S3.1","article-title":"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis","volume":"16","author":"Watts","year":"2010","journal-title":"Endocr Pract"},{"key":"2020071612020144500_B2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3299","article-title":"Emerging therapeutic opportunities for skeletal restoration","volume":"10","author":"Kawai","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"2020071612020144500_B3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jbmr.262","article-title":"The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?","volume":"26","author":"Khosla","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071612020144500_B4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis","volume":"31","author":"Manolagas","year":"2010","journal-title":"Endocr Rev"},{"key":"2020071612020144500_B5","first-page":"3128","article-title":"The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone","volume":"82","author":"Tomkinson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612020144500_B6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1359\/JBMR.050307","article-title":"Ovariectomy-induced bone loss varies among inbred strains of mice","volume":"20","author":"Bouxsein","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2020071612020144500_B7","first-page":"S3","article-title":"AHRQ\u2019s comparative effectiveness review of treatments to prevent fractures in men and women with low bone density or osteoporosis: a summary of the key findings","volume":"18","author":"Levis","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"2020071612020144500_B8","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2020071612020144500_B9","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1073\/pnas.97.11.5930","article-title":"Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling","volume":"97","author":"Russell","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612020144500_B10","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1172\/JCI43756","article-title":"Rapid progress for non-nuclear estrogen receptor signaling","volume":"120","author":"Mendelsohn","year":"2010","journal-title":"J Clin Invest"},{"key":"2020071612020144500_B11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/endo.142.2.7977","article-title":"Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase","volume":"142","author":"Armour","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612020144500_B12","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1210\/en.2006-0334","article-title":"Bone re\/modeling is more dynamic in the endothelial nitric oxide synthase(\u2212\/\u2212) mouse","volume":"147","author":"Grassi","year":"2006","journal-title":"Endocrinology"},{"key":"2020071612020144500_B13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/8756-3282(96)00005-1","article-title":"Nitric oxide donor alleviates ovariectomy-induced bone loss","volume":"18","author":"Wimalawansa","year":"1996","journal-title":"Bone"},{"key":"2020071612020144500_B14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S8756-3282(02)00955-9","article-title":"Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia","volume":"32","author":"Hukkanen","year":"2003","journal-title":"Bone"},{"key":"2020071612020144500_B15","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1359\/jbmr.1998.13.11.1755","article-title":"Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures","volume":"13","author":"Jamal","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071612020144500_B16","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1359\/jbmr.060804","article-title":"Decreased fracture risk in users of organic nitrates: a nationwide case-control study","volume":"21","author":"Rejnmark","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2020071612020144500_B17","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1210\/jc.2009-2342","article-title":"Use of organic nitrates and the risk of hip fracture: a population-based case-control study","volume":"95","author":"Pouwels","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612020144500_B18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jama.2011.176","article-title":"Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial","volume":"305","author":"Jamal","year":"2011","journal-title":"JAMA"},{"key":"2020071612020144500_B19","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1210\/jc.2008-2225","article-title":"Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss","volume":"94","author":"Wimalawansa","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612020144500_B20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11914-011-0087-7","article-title":"Nitric oxide donors for the treatment of osteoporosis","volume":"10","author":"Jamal","year":"2012","journal-title":"Curr Osteoporos Rep"},{"key":"2020071612020144500_B21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1172\/JCI21003","article-title":"Nitrate tolerance, oxidative stress, and mitochondrial function: another worrisome chapter on the effects of organic nitrates","volume":"113","author":"Parker","year":"2004","journal-title":"J Clin Invest"},{"key":"2020071612020144500_B22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1074\/jbc.M111.294959","article-title":"Pro-survival effects of 17\u03b2-estradiol on osteocytes are mediated by nitric oxide\/cGMP via differential actions of cGMP-dependent protein kinases I and II","volume":"287","author":"Marathe","year":"2012","journal-title":"J Biol Chem"},{"key":"2020071612020144500_B23","doi-asserted-by":"crossref","first-page":"ra91","DOI":"10.1126\/scisignal.2001423","article-title":"Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts","volume":"3","author":"Rangaswami","year":"2010","journal-title":"Sci Signal"},{"key":"2020071612020144500_B24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/bbrc.2000.3164","article-title":"The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent","volume":"274","author":"Mancini","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612020144500_B25","doi-asserted-by":"crossref","first-page":"C1311","DOI":"10.1152\/ajpcell.1996.270.5.C1311","article-title":"cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells","volume":"270","author":"Hagiwara","year":"1996","journal-title":"Am J Physiol"},{"key":"2020071612020144500_B26","doi-asserted-by":"crossref","first-page":"H1347","DOI":"10.1152\/ajpheart.00544.2011","article-title":"Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia\/reperfusion injury: role of hydrogen sulfide","volume":"302","author":"Salloum","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071612020144500_B27","first-page":"19","article-title":"Osteoblast isolation from murine calvariae and long bones","volume":"80","author":"Bakker","year":"2003","journal-title":"Methods Mol Med"},{"key":"2020071612020144500_B28","doi-asserted-by":"crossref","first-page":"14796","DOI":"10.1074\/jbc.M806486200","article-title":"Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction","volume":"284","author":"Rangaswami","year":"2009","journal-title":"J Biol Chem"},{"key":"2020071612020144500_B29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2020071612020144500_B30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1006\/bbrc.2000.3714","article-title":"Nitric oxide mediates 17\u03b2-estradiol-stimulated human and rodent osteoblast proliferation and differentiation","volume":"277","author":"O\u2019Shaughnessy","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612020144500_B31","first-page":"29","article-title":"Mineralizing fibroblast-colony-forming assays","volume":"80","author":"Scutt","year":"2003","journal-title":"Methods Mol Med"},{"key":"2020071612020144500_B32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1210\/en.2003-1089","article-title":"Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice","volume":"145","author":"M\u00f6dder","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612020144500_B33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5551\/jat.No083","article-title":"Relationship of urinary cGMP excretion with aging and menopausal status in a general population","volume":"16","author":"Cui","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"2020071612020144500_B34","doi-asserted-by":"crossref","first-page":"B183","DOI":"10.1093\/gerona\/55.4.B183","article-title":"Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women","volume":"55","author":"Hayashi","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2020071612020144500_B35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5414\/CPP40150","article-title":"Effect of two oral contraceptives containing ethinylestradiol and levonorgestrel on serum and urinary surrogate markers of endothelial function","volume":"40","author":"Seeger","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2020071612020144500_B36","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","article-title":"Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate","volume":"105","author":"Pederson","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612020144500_B37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/me.2009-0354","article-title":"The estrogen receptor-a in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone","volume":"24","author":"Martin-Millan","year":"2010","journal-title":"Mol Endocrinol"},{"key":"2020071612020144500_B38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"2020071612020144500_B39","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1359\/jbmr.2001.16.9.1665","article-title":"Human parathyroid hormone 1\u201334 reverses bone loss in ovariectomized mice","volume":"16","author":"Alexander","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2020071612020144500_B40","doi-asserted-by":"crossref","first-page":"28164","DOI":"10.1074\/jbc.M110.101964","article-title":"Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL","volume":"285","author":"Pierroz","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071612020144500_B41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature11000","article-title":"Osteoprotection by semaphorin 3A","volume":"485","author":"Hayashi","year":"2012","journal-title":"Nature"},{"key":"2020071612020144500_B42","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/en.2010-0930","article-title":"The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation","volume":"152","author":"Sophocleous","year":"2011","journal-title":"Endocrinology"},{"key":"2020071612020144500_B43","first-page":"719","article-title":"Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity","volume":"104","author":"Kousteni","year":"2001","journal-title":"Cell"},{"key":"2020071612020144500_B44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"2020071612020144500_B45","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/endo.139.2.5910","article-title":"Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells","volume":"139","author":"Armour","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612020144500_B46","first-page":"3056","article-title":"Decreased nitric oxide levels and bone turnover in amenorrheic athletes with spinal osteopenia","volume":"83","author":"Stacey","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612020144500_B47","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/01.HYP.25.4.848","article-title":"Circulating nitric oxide (nitrite\/nitrate) levels in postmenopausal women substituted with 17 \u03b2-estradiol and norethisterone acetate. A two-year follow-up study","volume":"25","author":"Rosselli","year":"1995","journal-title":"Hypertension"},{"key":"2020071612020144500_B48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-8703(99)70163-8","article-title":"Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group","volume":"138","author":"Nakamura","year":"1999","journal-title":"Am Heart J"},{"key":"2020071612020144500_B49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","article-title":"NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle","volume":"136","author":"Stasch","year":"2002","journal-title":"Br J Pharmacol"},{"key":"2020071612020144500_B50","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1210\/en.2004-0205","article-title":"Regulation of bone mass and bone turnover by neuronal nitric oxide synthase","volume":"145","author":"van\u2019t Hof","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612020144500_B51","doi-asserted-by":"crossref","first-page":"15809","DOI":"10.1074\/jbc.M513225200","article-title":"RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-\u03b2 via NF-\u03baB that restrains osteoclastogenesis and bone resorption","volume":"281","author":"Zheng","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071612020144500_B52","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1073\/pnas.92.7.2954","article-title":"Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms","volume":"92","author":"Brandi","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612020144500_B53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/8756-3282(96)00101-9","article-title":"Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins","volume":"19","author":"Ralston","year":"1996","journal-title":"Bone"},{"key":"2020071612020144500_B54","first-page":"F283","article-title":"Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism","volume":"272","author":"Holliday","year":"1997","journal-title":"Am J Physiol"},{"key":"2020071612020144500_B55","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/jcb.20009","article-title":"Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts","volume":"91","author":"Yaroslavskiy","year":"2004","journal-title":"J Cell Biochem"},{"key":"2020071612020144500_B56","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1242\/jcs.02655","article-title":"O-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP","volume":"118","author":"Yaroslavskiy","year":"2005","journal-title":"J Cell Sci"},{"key":"2020071612020144500_B57","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/me.2012-1368","article-title":"Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass","volume":"27","author":"Bartell","year":"2013","journal-title":"Mol Endocrinol"},{"key":"2020071612020144500_B58","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1210\/en.2010-0399","article-title":"Suppression of NF-\u03baB increases bone formation and ameliorates osteopenia in ovariectomized mice","volume":"151","author":"Alles","year":"2010","journal-title":"Endocrinology"},{"key":"2020071612020144500_B59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat Med"},{"key":"2020071612020144500_B60","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/jbmr.350","article-title":"Interferon-\u03b3 plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice","volume":"26","author":"Duque","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071612020144500_B61","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmet.2007.05.001","article-title":"Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction","volume":"5","author":"Tatsumi","year":"2007","journal-title":"Cell Metab"},{"key":"2020071612020144500_B62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell \u2026 and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr Rev"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/155\/12\/4720\/10827915\/endo4720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/155\/12\/4720\/10827915\/endo4720.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T18:39:25Z","timestamp":1594924765000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/155\/12\/4720\/2423041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2014-1343","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}